A Laupacis
Overview
Explore the profile of A Laupacis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
6736
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiu J, Apriasz I, Alkhamesi N, Lal A, Lindsay D, Smith L, et al.
Can J Surg
. 2022 Apr;
54(4):S57-S104.
PMID: 35488394
No abstract available.
2.
Dainty K, Seaton M, Cowan K, Laupacis A, Dorian P, Douma M, et al.
Resusc Plus
. 2021 Jul;
7:100148.
PMID: 34286310
Background: Research priority setting in health care has historically been done by expert health care providers and researchers and has not involved patients, family or the public. Survivors & family...
3.
Bartoszko J, Thorpe K, Laupacis A, Wijeysundera D
Br J Anaesth
. 2019 Jun;
123(2):161-169.
PMID: 31227271
Background: Preoperative anaemia is associated with elevated risks of postoperative complications. This association may be explained by confounding related to poor cardiopulmonary fitness. We conducted a pre-specified substudy of the...
4.
Srikanthan A, Mai H, Penner N, Amir E, Laupacis A, Sabharwal M, et al.
Curr Oncol
. 2017 Nov;
24(5):295-301.
PMID: 29089796
Background: The pan-Canadian Oncology Drug Review (pcodr) was implemented in 2011 to address uneven drug coverage and lack of transparency with respect to the various provincial cancer drug review processes...
5.
Sapir-Pichhadze R, Pintilie M, Tinckam K, Laupacis A, Logan A, Beyene J, et al.
Am J Transplant
. 2016 Jan;
16(7):1958-66.
PMID: 26751409
Competing events (or risks) preclude the observation of an event of interest or alter the probability of the event's occurrence and are commonly encountered in transplant outcomes research. Transplantation, for...
6.
Sapir-Pichhadze R, Tinckam K, Quach K, Logan A, Laupacis A, John R, et al.
Am J Transplant
. 2014 Dec;
15(1):137-48.
PMID: 25521856
We conducted a nested case-control study from a cohort of adult kidney transplant recipients to assess the risk of transplant glomerulopathy (TG) as a function of donor and recipient HLA-DR...
7.
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron J, et al.
Lancet
. 2013 Jun;
382(9894):769-79.
PMID: 23726390
Background: The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at...
8.
Grasselli G, Gattinoni L, Kavanagh B, Latini R, Laupacis A, Lemaire F, et al.
Minerva Anestesiol
. 2007 Oct;
73(11):595-601.
PMID: 17952032
In critical care medicine there is still a paucity of evidence on how to manage most of the clinical problems commonly encountered in critically ill patients. Randomized controlled trials (RCTs)...
9.
Henry D, Carless P, Moxey A, OCONNELL D, Stokes B, McClelland B, et al.
Cochrane Database Syst Rev
. 2007 Oct;
(4):CD001886.
PMID: 17943760
Background: Concerns regarding the safety of transfused blood have led to the development of a range of interventions to minimise blood loss during major surgery. Anti-fibrinolytic drugs are widely used,...
10.
Shah B, Hux J, Laupacis A, Zinman B, Booth G
Diabet Med
. 2006 Sep;
23(10):1117-23.
PMID: 16978377
Aims: Although heart disease and stroke are the underlying causes of death in most people with diabetes, vascular risk modification targets are frequently not met. This study examined whether vascular...